Skip to content

Pulmonary Rehabilitation in Interstitial Lung Disease

Pulmonary Rehabilitation in Interstitial Lung Disease - a Multi-Centre, Single-Blinded Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00168285
Enrollment
56
Registered
2005-09-15
Start date
2005-03-31
Completion date
2007-05-31
Last updated
2007-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Keywords

Exercise, Pulmonary rehabilitation, Idiopathic pulmonary fibrosis, Connective tissue disorders

Brief summary

Interstitial lung disease (ILD) is a highly disabling group of conditions including idiopathic pulmonary fibrosis (IPF), acute and chronic interstitial pneumonias, connective tissue diseases and sarcoidosis. People with ILD frequently experience breathlessness on exertion, which limits their ability to undertake daily activities. People with ILD report very poor quality of life due to low levels of physical functioning and vitality, and high levels of breathlessness and fatigue. There are few treatments for ILD and those that are available have limited impact on quality of life. The aim of this study is to assess the effects of Pulmonary Rehabilitation, which consists of specialised exercise training for people with lung disease, on exercise capacity and quality of life in people with ILD. We hypothesis that exercise training will result in reduced dyspnoea, improved exercise tolerance and enhanced quality of life.

Detailed description

Interstitial lung disease (ILD) is a highly disabling group of conditions including idiopathic pulmonary fibrosis (IPF), acute and chronic interstitial pneumonias, connective tissue diseases and sarcoidosis. People with ILD frequently experience breathlessness on exertion, which limits their ability to undertake daily activities and reduces health-related quality of life.Available treatments for ILD have proved largely ineffective, offering no improvement in survival and demonstrating only limited impact on quality of life. Aims of the Research 1. Evaluate the effects of Pulmonary Rehabilitation on exercise capacity and quality of life in patients with ILD 2. Determine the physiological response to Pulmonary Rehabilitation in patients with ILD 3. Determine the relationship between the aetiology and severity of ILD and the effects of Pulmonary Rehabilitation. Comparisons: 8 weeks exercise training compared to control group (maximal exercise capacity, functional exercise capacity, dyspnoea, quality of life).

Interventions

BEHAVIORALPulmonary Rehabilitation

Sponsors

La Trobe University
CollaboratorOTHER
Austin Hospital, Melbourne Australia
CollaboratorOTHER
Victorian Tuberculosis and Lung Association
CollaboratorUNKNOWN
The Alfred
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Ambulant * Stable medical therapy * Dyspnoea on exertion following maximal treatment

Exclusion criteria

* A history of syncope on exertion * Too unwell to attend the hospital for exercise training * Any other comorbidities which would prevent exercise training * Previous Pulmonary Rehabilitation in the last 12 months

Design outcomes

Primary

MeasureTime frame
Functional exercise capacity

Secondary

MeasureTime frame
Maximal exercise capacity
Health-related quality of life
Dyspnoea

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026